Skip to main content
  • Saved

from Pathologist Connect made a Post

In a new study published online today in JAMA Oncology, researchers show that patients harboring a KRAS gene mutation with high levels of PDL-1 lived longer when treated with immunotherapy alone, compared to patients without this mutation.

Immunotherapy Alone Extended Life for Metastatic Lung Cancer Patients with KRAS Mutation - Penn Medicine

Immunotherapy Alone Extended Life for Metastatic Lung Cancer Patients with KRAS Mutation - Penn Medicine

Source :

https://www.pennmedicine.org/news/news-releases/2021/april/immunotherapy-alone-extended-life-for-metastatic-lung-cancer-patients-with-kras-mutation

Real-word evidence is suggesting, for the first time, the most beneficial treatment courses that could help extend the lives of patients with metastatic non-small cell lung cancer, according to research from the Abramson Cancer Center at the University of Pennsylvania.